Chemotherapy-Related Tumour Lysis Syndrome

dc.contributor.authorBusakhala, N. W.
dc.contributor.otherAssociation of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)en
dc.date.accessioned2007-11-19T23:01:56Z
dc.date.available2007-11-19T23:01:56Z
dc.date.issued2007
dc.description.abstractTwo types of tumour lysis syndrome (TLS) ; 1. Laboratory TLS: 25% increase in potassium, phosphate and uric acid, or decline in calcium from baseline. Occur within 4 days of initiating chemotherapy. Patients on standard of care. Minimum of two out of four criteria. 2. Clinical tumour lysis syndrome: Laboratory TLS plus renal failure, cardiac arrhythmias or sudden death. A new definition has been suggested by Cairo and Bishop to include values above upper limit of normal. Study used Hande and Garrow definition.en
dc.identifier.urihttps://hdl.handle.net/1805/1181
dc.languageEnglishen
dc.language.isoenen
dc.publisherAssociation of Kenya Physiciansen
dc.subjecttumour lysis syndromeen
dc.subjectTLSen
dc.subjectrenalen
dc.subjectcardiacen
dc.subjectHande and Garrowen
dc.subjectgouten
dc.subjecttumoren
dc.subjecthyperkalemiaen
dc.subjecthyperphosphatemiaen
dc.subject.lcshChemotherapy
dc.subject.meshTumor Lysis Syndrome
dc.subject.meshKidney Failure
dc.subject.meshDrug Therapy
dc.subject.meshArrhythmia
dc.titleChemotherapy-Related Tumour Lysis Syndromeen
dc.typePresentationen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
TLS PRESENTATION Dr Busakhala.pdf
Size:
390.85 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.93 KB
Format:
Item-specific license agreed upon to submission
Description: